Neurocrine Biosciences Inc

NBIX Com Stk NPV (CDI)
Create an alert
Sell$146.13
Buy$146.17
$5.60 (3.69%)
Last updated today at
Back to dashboard

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
14 September 2026
Mathew C AbernethyCFO
Sell
Option/Award related
2,311$157.20$363,284.8142,808
14 September 2026
David Warren (Dave) BoyerChief Level Officer
Sell
Option/Award related
826$157.45$130,050.568,722
11 September 2026
Kevin Charles GormanOther Level A
Sell
Tax related
7,839$156.22$1,224,608.58517,797
11 September 2026
Kyle W. GanoPresident/CEO
Sell
Tax related
994$156.22$155,282.68154,728
11 September 2026
Kyle W. GanoPresident/CEO
Sell
Tax related
3,386$156.22$528,960.92153,880
11 September 2026
Eric S. BenevichChief Level Officer
Sell
Tax related
3,386$156.22$528,960.9267,297
11 September 2026
Darin LippoldtChief Legal/Compliance Officer
Sell
Tax related
2,419$156.22$377,896.1856,793
11 September 2026
Mathew C AbernethyCFO
Sell
Tax related
2,709$156.22$423,199.9845,119
11 September 2026
Julie Smith CookeGroup Director
Sell
Tax related
1,936$156.22$302,441.9224,025
11 September 2026
Jude OnyiaChief Level Officer
Sell
Tax related
1,936$156.22$302,441.9222,647

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
19 May 2026
Kevin Charles GormanOther Level A
Sell
Regular sell transaction (market)
245,088$154.33$37,824,872.20511,293
16 January 2026
Kyle W. GanoPresident/CEO
Sell
Option/Award related
34,588$132.70$4,589,979.79140,407
13 February 2026
Kevin Charles GormanOther Level A
Sell
Tax related
34,380$124.12$4,267,245.60551,293
5 November 2025
William H. (Bill) RastetterChairman of the Board
Sell
Option/Award related
18,000$151.82$2,732,689.8040,360
15 May 2026
Richard F PopsIndependent Director
Sell
Option/Award related
15,000$157.65$2,364,760.5034,480

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.